Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Recruiting 16Completed 14Active not recruiting 7Unknown 5Terminated 5Withdrawn 3

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 51Gynecologic 5Tumor-Agnostic 1Other solid neoplasm 1Other 1

Conditions

Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Recurrence 1Hydatidiform Mole 1Gestational Trophoblastic Disease 1Endometrioid Endometrial Cancer 1Endometrial Neoplasms 1

Interventions

Paclitaxel 77Carboplatin 71Cisplatin 70Radiotherapy 27Bevacizumab 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 18Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 14liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Taxes 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Cytoreduction Surgical Procedures 7Albumin-Bound Paclitaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Letrozole × Gynecologic × Clear all
NCT06243185 2024-02-06

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Peking Union Medical College Hospital

Phase 2 Unknown
30 enrolled
Gynecologic

Ovarian Neoplasms

NCT05705505 2023-12-12

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

Traws Pharma, Inc.

Phase 1/2 Unknown
60 enrolled
Gynecologic

Endometrioid Endometrial Cancer

NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Zagazig University

Phase 2/3 Unknown
200 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT02482740 2015-06-26

TGOG1005

Buddhist Tzu Chi General Hospital

Phase 2 Unknown
44 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02188550 2015-05-19

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Sinai Hospital of Baltimore

Phase 2 Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡